- Home
- SPGI vs PFE Comparison
SPGI vs PFE Comparison
Compare SPGI & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPGI
- PFE
- Stock Information
- Founded
- SPGI 1860
- PFE 1849
- Country
- SPGI United States
- PFE United States
- Employees
- SPGI N/A
- PFE N/A
- Industry
- SPGI Finance: Consumer Services
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- SPGI Finance
- PFE Health Care
- Exchange
- SPGI Nasdaq
- PFE Nasdaq
- Market Cap
- SPGI 162.8B
- PFE 166.8B
- IPO Year
- SPGI N/A
- PFE N/A
- Fundamental
- Price
- SPGI $518.73
- PFE $29.28
- Analyst Decision
- SPGI Buy
- PFE Buy
- Analyst Count
- SPGI 13
- PFE 12
- Target Price
- SPGI $575.45
- PFE $33.91
- AVG Volume (30 Days)
- SPGI 934.4K
- PFE 30.6M
- Earning Date
- SPGI 10-24-2024
- PFE 10-29-2024
- Dividend Yield
- SPGI 0.70%
- PFE 5.74%
- EPS Growth
- SPGI 45.81
- PFE N/A
- EPS
- SPGI 10.53
- PFE N/A
- Revenue
- SPGI $13,276,000,000.00
- PFE $55,166,000,000.00
- Revenue This Year
- SPGI $11.74
- PFE $5.66
- Revenue Next Year
- SPGI $7.15
- PFE $3.34
- P/E Ratio
- SPGI $49.29
- PFE N/A
- Revenue Growth
- SPGI 10.09
- PFE N/A
- 52 Week Low
- SPGI $340.49
- PFE $25.20
- 52 Week High
- SPGI $533.29
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- SPGI 51.63
- PFE 50.84
- Support Level
- SPGI $513.95
- PFE $28.85
- Resistance Level
- SPGI $533.29
- PFE $29.82
- Average True Range (ATR)
- SPGI 7.42
- PFE 0.53
- MACD
- SPGI 0.33
- PFE 0.04
- Stochastic Oscillator
- SPGI 48.28
- PFE 47.26
About SPGI S&P Global Inc.
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.